ZA991786B - Therapeutic treatment for asthma. - Google Patents

Therapeutic treatment for asthma.

Info

Publication number
ZA991786B
ZA991786B ZA9901786A ZA991786A ZA991786B ZA 991786 B ZA991786 B ZA 991786B ZA 9901786 A ZA9901786 A ZA 9901786A ZA 991786 A ZA991786 A ZA 991786A ZA 991786 B ZA991786 B ZA 991786B
Authority
ZA
South Africa
Prior art keywords
asthma
therapeutic treatment
therapeutic
treatment
Prior art date
Application number
ZA9901786A
Other languages
English (en)
Inventor
Douglas Kirk Ways
Original Assignee
Elil Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elil Lilly And Company filed Critical Elil Lilly And Company
Publication of ZA991786B publication Critical patent/ZA991786B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9901786A 1998-03-05 1999-03-05 Therapeutic treatment for asthma. ZA991786B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7685098P 1998-03-05 1998-03-05

Publications (1)

Publication Number Publication Date
ZA991786B true ZA991786B (en) 1999-09-06

Family

ID=22134565

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901786A ZA991786B (en) 1998-03-05 1999-03-05 Therapeutic treatment for asthma.

Country Status (7)

Country Link
US (1) US6103712A (fr)
EP (1) EP0940143A3 (fr)
JP (1) JP2002505284A (fr)
AU (1) AU3071899A (fr)
CA (1) CA2323173A1 (fr)
WO (1) WO1999044606A1 (fr)
ZA (1) ZA991786B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492406B1 (en) 1999-05-21 2002-12-10 Astrazeneca Ab Pharmaceutically active compounds
EP1541579A1 (fr) * 2002-06-20 2005-06-15 Nippon Suisan Kaisha, Ltd. Promedicament, utilisation de ce dernier en medecine et procede de production de ce promedicament
US20050164323A1 (en) * 2003-12-24 2005-07-28 Wyeth Methods of treating asthma
EP2177510A1 (fr) 2008-10-17 2010-04-21 Universität des Saarlandes Modulateurs allostériques de protéine kinase

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ280738B6 (cs) * 1988-02-10 1996-04-17 F. Hoffmann - La Roche And Co., Aktiengesellschaft Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi
ZA908934B (en) * 1989-11-13 1991-08-28 Merrell Dow Pharma Novel pyridyloxazole-2-ones useful as proteinkinase c inhibitors
US5565448A (en) * 1992-02-24 1996-10-15 Smithkline Beecham Corporation Medicament
US5516775A (en) * 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives
NO308798B1 (no) * 1993-12-07 2000-10-30 Lilly Co Eli Proteinkinase-C-hemmere, anvendelse av samme for fremstilling av farmasøytika samt farmasøytisk formulering omfattende samme
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
DK0657411T3 (da) * 1993-12-07 1999-11-15 Lilly Co Eli Forbedret syntese af bisindolylmaleimider
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5559228A (en) * 1995-03-30 1996-09-24 Eli Lilly And Company Synthesis of bisindolylmaleimides
YU49315B (sh) * 1995-11-20 2005-06-10 Elli Lilly And Company Inhibitor protein kinaze c, njegove farmaceutske formulacije i postupak za dobijanje
EP0915698A4 (fr) * 1996-05-01 1999-08-11 Lilly Co Eli Traitement therapeutique des maladies liees au facteur de croissance de l'endothelium vasculaire
ES2170390T3 (es) * 1996-05-30 2002-08-01 Aventis Pharma Inc Fluorenonas alquiloxiamino-substituidas y su uso como inhibidores de la proteina kinasa-c.
SE9603283D0 (sv) * 1996-09-10 1996-09-10 Astra Ab New compounds

Also Published As

Publication number Publication date
JP2002505284A (ja) 2002-02-19
CA2323173A1 (fr) 1999-09-10
WO1999044606A1 (fr) 1999-09-10
EP0940143A3 (fr) 1999-09-22
US6103712A (en) 2000-08-15
AU3071899A (en) 1999-09-20
EP0940143A2 (fr) 1999-09-08

Similar Documents

Publication Publication Date Title
GB9804885D0 (en) Therapeutic combination
IL142588A0 (en) Therapy for improving cognition
GB9800942D0 (en) Well treatment
ZA979731B (en) Treatment of asthma.
GB9907243D0 (en) Therapy
GB9930570D0 (en) Therapy
GB9816556D0 (en) Therapy
ZA200105690B (en) Novel treatment.
ZA991786B (en) Therapeutic treatment for asthma.
ZA991783B (en) Therapeutic treatment for autoimmune diseases.
ZA991785B (en) Therapeutic treatment for cytomegalovirus infection.
GB0020261D0 (en) Therapeutic treatment
GB9810920D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
GB9816897D0 (en) Therapeutic use
GB9804361D0 (en) Cancer treatment
GB9815497D0 (en) Treatment
GB9818524D0 (en) Inorgasmia treatment
GB9811624D0 (en) Therapeutic use
GB9812664D0 (en) Therapeutic use
GB9806039D0 (en) Therapy
GB9828550D0 (en) Treatment
ZA99220B (en) Triazepinones, process for their preparation and their therapeutic application.
GB9812914D0 (en) Treatment
AU1167P (en) Treat xTriticosecale